Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
32,893,048
-
Share change
-
+1,683,806
-
Total reported value
-
$390,439,854
-
Price per share
-
$11.87
-
Number of holders
-
68
-
Value change
-
+$18,473,548
-
Number of buys
-
33
-
Number of sells
-
25
Institutional Holders of ALIGOS THERAPEUTICS INC - COM NEW (ALGS) as of Q4 2021
As of 31 Dec 2021,
ALIGOS THERAPEUTICS INC - COM NEW (ALGS) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,893,048 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, Logos Global Management LP, Novo Holdings A/S, JANUS HENDERSON GROUP PLC, HHLR ADVISORS, LTD., Versant Venture Management, LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., and BOXER CAPITAL, LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.